Cardiology
19 November, 2026
Eur Heart J Case Rep. 2026 Oct 31;10(11):ytag783. doi: 10.1093/ehjcr/ytag783. eCollection 2026 Nov.
ABSTRACT
BACKGROUND: Loeffler endocarditis is a rare form of cardiomyopathy caused by eosinophilic infiltration of the endocardium with endomyocardial fibrosis and thrombus formation. It carries significant risk for systemic thromboembolism. This case described the successful medical management of a massive left ventricular thrombus and highlighted the role of cardiac magnetic resonance (CMR) in this condition.
CASE SUMMARY: A 54-year-old female with eosinophilic granulomatosis with polyangiitis with a heart murmur underwent an echocardiogram showing dilated cardiomyopathy with left ventricular ejection fraction of 39%. Follow-up CMR showed apical predominant endomyocardial fibrosis with a large apical thrombus consistent with Loeffler endocarditis. The clinical course was complicated by direct oral anticoagulant (DOAC) failure and intolerance of immunosuppression, requiring warfarin and biologic (mepolizumab) therapy. The patient has remained free of systemic thromboembolic events while on immunosuppression and systemic anticoagulation.
DISCUSSION: There is limited data on the management of Loeffler endocarditis. The widespread availability of CMR can allow for early diagnosis of cardiac involvement in eosinophilic and other inflammatory conditions. Despite common cardiac involvement in eosinophilic diseases, there are no universal screening guidelines for echocardiography or CMR. Anticoagulation in the setting of Loeffler endocarditis is based on guidelines and retrospective studies demonstrating safety of DOAC. If cardiac involvement is suspected in eosinophilic diseases, early CMR can allow for detection and prevention of complications from Loeffler endocarditis.
PMID:43054824 | PMC:PMC13779823 | DOI:10.1093/ehjcr/ytag783
European Heart Journal
© 2026 Imedsource, All Rights Reserved
For unrestricted access to content and a seamless experience,
Complete your profile to help us deliver a more personalized experience.